Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 204
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT02444819 | Phase II Trial to Evaluate the Efficacy and Safety of HM61713 as the 1st-line NSCLC Anticancer Therapy | ||
| NCT01455584 | Clinical Trial to Determine the MTD of HM781-36B in Patients With Advanced Solid Tumors | ||
| NCT02059564 | A Phase 1b Study of LAPS-Exendin in Subjects of Type 2 Diabetes Mellitus | ||
| NCT04762407 | A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of HCP1903 | ||
| NCT01718847 | NOV120101 Phase 2 Study in NSCLC Patients With Aquired Resistance to 1st Generation EGFR Tyrosine Kinase Inhibitors | ||
| NCT01463982 | Phase I of OratecanTM in Combination With Capecitabine in Patients With Advanced Solid Malignancies | ||
| NCT06174766 | A Study to Evaluate Efficacy and Safety of HGP2102 in Essential Hypertension Patients | ||
| NCT03284502 | HM95573 in Combination With Either Cobimetinib or Cetuximab in Patients With Locally Advanced or Metastatic Solid Tumors | ||
| NCT01765478 | Safety,PK/PD, Food Effect Study of Orally Administered HM71224 in Healthy Adult Male Volunteers | ||
| NCT04322266 | A Study to Compare the Pharmacokinetics, Safety and Tolerability Between Fixed-Dose Combination and Co-Administration of HGP0904, HGP0608 and HCP1306 Tablets in Healthy Male Subjects. | ||
| NCT01505777 | Exploratory Clinical Study to Evaluate the Optimal Dosage of Mosapride and Probiotics in Irritable Bowel Syndrome Without Predominant Diarrhea | ||
| NCT06346184 | A Study to Evaluate the Pharmacokinetics and Safety Between HCP2303 and Co-administration of Each Component in Healthy Volunteers | ||
| NCT01822340 | Safety and Efficacy Study of Recombinant Human Growth Hormone in Adult Growth Hormone Deficiency Patients | ||
| NCT02667938 | A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of HCP1303 Capsules | ||
| NCT05487560 | An Observational Study to Evaluate the Incidence of MACCE According to Time Interval of Taking Medication in Patients With Acute Coronary Syndrome or Cerebral Infarction Who Received DAPT for the Secondary Prevention and Esomezol Cap for the Prevention of Gastrointestinal Bleeding | ||
| NCT00940680 | Efficacy/Safety of Amlodipine Plus Losartan Versus Losartan in Patients With Essential Hypertension | ||
| NCT04252963 | Clinical Trial to Assess the Efficacy and Safety of MUCOLASE Tablet(Streptokinase • Streptodornase) | ||
| NCT02057887 | Safety,Tolerability and Pharmacokinetic Study of Recombinant Human Interferon Alfa 2B in Chronic Hepatitis C Patients (HM10660A) | ||
| NCT02545829 | Evaluating the Bioequivalence of HIP1302, HGP1406 | ||
| NCT03118817 | Expansion Study to Evaluate the Efficacy and Safety of HM95573 in BRAF, KRAS or NRAS Mutant Solid Cancers | ||
| NCT03374241 | A First-in-human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HM15211(Efocipegtrutide) | ||
| NCT03882112 | Food-effect on PK and PD of Single Oral Dose of HIP1601 in Healthy Male Subjects | ||
| NCT01588145 | Phase I/II Trial to Evaluate Safety, Tolerability and Pharmacokinetic Profile of HM61713 in NSCLC Patients | ||
| NCT01830517 | Diurnal Variation in Hypertensive Stroke Patients | ||
| NCT01037543 | Safety and PK of HM10460A (HNK460) in Healthy Adult Japanese and Caucasian Subjects | ||
| NCT02127320 | Investigating the Pharmacokinetic Drug Interactions Between Rosuvastatin and Ezetimibe | ||
| NCT01127217 | Efficacy/Safety of Amlodipine Plus Losartan Versus Amlodipine in Patients With Stage 2 Hypertension | ||
| NCT03228277 | Olmutinib Trial in T790M (+) NSCLC Patients Detected by Liquid Biopsy Using BALF Extracellular Vesicular DNA | ||
| NCT02405065 | Clinical Trial to Evaluate Safety, Tolerability and Pharmacokinetics and Anti-tumor Activity of HM95573 | ||
| NCT04325620 | Safety to Evaluate the Efficacy and Safety of HIP1601 in Patients With Non Erosive Reflux Disease | ||
| NCT03479073 | Risk Factors of Stroke or Systemic Embolism After Atrial Fibrillation Ablation | ||
| NCT01913847 | Safety and Efficacy Study of HGP1207 in Patients With Pulmonary Hypertension | ||
| NCT02587988 | Trial to Evaluate the Efficacy and Safety of HCP1302 | ||
| NCT06858397 | A proof-of Concept Study to Assess Safety and Tolerability of HM15421/GC1134A in Patients With Fabry Disease | ||
| NCT01819428 | NOV120101 (Poziotinib) for 1st Line Monotherapy in Patients With Lung Adenocarcinoma | ||
| NCT01197014 | A Bioequivalence Study of Amlodipine Plus Losartan Versus Amlodipine and Losartan | ||
| NCT05656092 | A Study to Evaluate the Effiacy and Safety of HIP0612 in Patients With Gastric Ulcer | ||
| NCT01504581 | Safety, Pharmacokinetic, Pharmacodynamic Study of LAPS-IFNa in Healthy Adult Subjects | ||
| NCT07449754 | Belvarafenib in Combination With Cobimetinib in Patients With Locally Advanced or Metastatic NRAS-Mutant Melanoma | ||
| NCT03426722 | L-carnitine vs Placebo for the Treatment of Muscle Cramps After Imatinib in Gastrointestinal Stromal Tumors | ||
| NCT07527650 | Study to Evaluate HM15275 in Subjects With Type 2 Diabetes Mellitus | ||
| NCT06357910 | A Study to Evaluate the Pharmacokinetics and Safety Between HCP2303 and Co-administration of Each Component in Healthy Volunteers Under Fed Conditions | ||
| NCT02390882 | A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of HGP0412 and HIP1402 in Patients With BPH | ||
| NCT03744182 | A Study of Multiple Doses of HM15211(Efocipegtrutide) in Obese Subjects With NAFLD | ||
| NCT04080726 | Efficacy and Safety of HIP1601 Capsule | ||
| NCT04510415 | Olmutinib 600 mg QD in Patients With T790M-positive NSCLC After Treatment With an EGFR-TKI | ||
| NCT02485652 | Phase II Trial of HM61713 for the Treatment of ≥2nd Line T790M Mutation Positive Adenocarcinoma of the Lung | ||
| NCT02387554 | Pharmacokinetic Interaction Between HGP0904, HGP0608 and HGP1405 | ||
| NCT02554136 | Evaluating a Pharmacokinetic Drug Interaction Between HGP0918 and HGP0816 | ||
| NCT03770728 | Efficacy and Safety of Efpeglenatide Versus Placebo in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Alone or in Combination With Sulfonylurea |
